Cytokine release and its modulation by dexamethasone in whole blood following exercise
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
SUMMARY: Glucocorticoids (GC) play an important role in the treatment of inflammatory diseases like asthma. However, in selected patients a relative resistance to GC has been reported. Recently, it has been suggested that GC sensitivity of peripheral blood leucocytes may be regulated in a dynamic fashion during exercise, in association with activation of the hypothalamic–pituitary–adrenal (HPA) axis. The aim of the present study was to explore changes in the GC sensitivity of cytokine production by leucocytes following strenuous exercise by well trained oarsmen. These changes were studied using lipopolysaccharide (LPS)-induced and anti-CD2/anti-CD28 MoAb-stimulated cytokine release in whole blood and its modulation by dexamethasone. Following exercise, significant decreases in LPS-induced release of IL-6, tumour necrosis factor-alpha (TNF-α) and IL-10 and anti-CD2/anti-CD28 MoAb-stimulated secretion of interferon-gamma (IFN-γ) were observed. In addition, the inhibitory effect of dexamethasone on both IL-6 and TNF-α secretion was significantly reduced following exercise, whereas that on IL-10 and IFN-γ release was not affected. These exercise-induced changes were accompanied by activation of the HPA axis, as indicated by an increase in circulating adrenocorticotropic hormone (ACTH) levels immediately following exercise. The results from the present study suggest that GC sensitivity of whole blood cytokine release can be regulated in a dynamic fashion and that this can be assessed using an ex vivo stimulation assay. Moreover, since dexamethasone responsiveness of anti-CD2/anti-CD28 MoAb-induced IFN-γ secretion in whole blood is not affected by exercise, it may suggest that exercise differentially affects monocytes and lymphocytes. The dynamic regulation of steroid responsiveness of leucocytes, as observed in the present study, could have important consequences for the effectiveness of GC treatment in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stimulation with LPS induces higher production of IL-6 and TNF-α and inhibits production of IL-10 in leukocytes in vitro. Addition of DEX inhibits these effects.”
From Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity (2021) · cites this paper as Smits et al. 1998
In the citing paper
“A crucial component of this system, the activity of the glucocorticoid receptor (GR), can be assessed ex vivo instead.”
From Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity (2021) · cites this paper as Smits et al. 1998
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642
Research works printed but not linked: 32
- Schwiebert, 1996, Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions, J Allergy Clin Immunol, 97, 143, 10.1016/S0091-6749(96)80214-4 · DOI · Paper page
- Abbinante-Nissen, 1995, Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells, Am J Physiol, 12, L601
- Van Furth, 1995, Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor-necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes, Clin Diagn Lab Immunol, 2, 689, 10.1128/cdli.2.6.689-692.1995 · DOI
- Cypcar, 1993, Steroid-resistant asthma, J Allergy Clin Immunol, 92, 362, 10.1016/0091-6749(93)90114-U · DOI
- Kirkham, 1991, Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell-mediated immune assay predicts in vivo response, J Rheumatol, 18, 1130
- Corrigan, 1991, Glucocorticoid resistance in chronic asthma: glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro, Am Rev Res Dis, 144, 101
- Spahn, 1996, Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma, J Allergy Clin Immunol, 98, 1073, 10.1016/S0091-6749(96)80194-1 · DOI
- Nijhuis, 1994, Decreased sensitivity to dexamethasone in lymphocytes from patients with Alzheimer's disease, Clin Immunol Immunopathol, 73, 45, 10.1006/clin.1994.1168 · DOI
- Adcock, 1995, Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma, J Immunol, 154, 3500, 10.4049/jimmunol.154.7.3500 · DOI · Paper page
- Rosewicz, 1988, Mechanism of glucocorticoid receptor down-regulation by glucocorticoids, J Biol Chem, 263, 2581, 10.1016/S0021-9258(18)69104-5 · DOI · Paper page
- Korn, 1997, In vitro and in vivo modulation of α- and β-glucocorticoidreceptor mRNA in human bronchial epithelium, Am J Resp Crit Care Med, 155, 1117, 10.1164/ajrccm.155.3.9116996 · doi:10.1164/ajrccm.155.3.9116996
- DeRijk, 1996, Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans, J Clin Endo Metabol, 81, 228
- Sauer, 1995, The glucocorticoid sensitivity of lymphocytes changes according to the activity of the hypothalamic–pituitary–adrenocortical system, Psychoneuroendocrinol, 20, 269, 10.1016/0306-4530(94)00058-I · DOI
- Brown, 1993, Regulation of mycobacterial growth by the hypothalamus–pituitary–adrenal axis: differential responses of Mycobacterium bovis BCC-resistant and -susceptible mice, Infect Immun, 61, 4793, 10.1128/iai.61.11.4793-4800.1993 · DOI
- Dunn, 1994, Neurochemical and neuroendocrine responses to Newcastle disease virus administration in mice, Brain Res, 645, 103, 10.1016/0006-8993(94)91643-8 · DOI
- Barnes, 1996, Mechanisms of action of glucocorticoids in asthma, Am J Resp Crit Care Med, 154, S21, 10.1164/ajrccm/154.2_Pt_2.S21 · DOI
- Brattsand, 1996, Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies, Aliment Pharmacol, 10, 81, 10.1046/j.1365-2036.1996.22164025.x · DOI · Paper page
- DeRijk, 1997, Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNFα) productions in humans: high sensitivity of TNFα and resistance of IL-6, J Clin Endo Metabol, 82, 2182
- Ertel, 1995, Downregulation of proinflammatory cytokine release in whole blood from septic patients, Blood, 85, 1341, 10.1182/blood.V85.5.1341.bloodjournal8551341 · DOI · Paper page
- Kremer, 1996, Interleukin-1, -6 and tumor necrosis factor-α release is down-regulated in whole blood from septic patients, Acta Haematol, 95, 268, 10.1159/000203895 · doi:10.1159/000203895
- Fischer, 1995, Selective suppression of cytokine secretion in patients with small-cell lung cancer, Anal Oncol, 6, 921, 10.1093/oxfordjournals.annonc.a059360 · doi:10.1093/oxfordjournals.annonc.a059360
- Dinarello, 1991, Interleukin-1 and interleukin-1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627 · DOI · Paper page
- Van der Pouw-Kraan, 1992, Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production, Eur J Immunol, 22, 1237, 10.1002/eji.1830220519 · DOI · Paper page
- Grbic, 1991, The role of prostaglandin E2 in immune suppression following injury, Ann Surg, 214, 253, 10.1097/00000658-199109000-00008 · DOI · Paper page
- Gearing, 1994, Processing of tumour necrosis factor-α precursor by metalloproteinases, Nature, 370, 555, 10.1038/370555a0 · DOI · Paper page
- McGeehan, 1994, Regulation of tumour necrosis factor-α processing by metalloproteinase inhibitor, Nature, 370, 558, 10.1038/370558a0 · DOI · Paper page
- Nijhuis, 1994, Abrogation of the suppressive effects of dexamethasone by PKC activation or CD28 triggering, Cell Immunol, 156, 438, 10.1006/cimm.1994.1188 · DOI
- Kavelaars, 1995, Increased dexamethasone sensitivity of neonatal leukocytes: different mechanisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells, Eur J Immunol, 25, 1346, 10.1002/eji.1830250532 · DOI
- Kam, 1993, Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids, J Immunol, 151, 346, 10.4049/jimmunol.151.7.3460 · DOI · Paper page
- Bamberger, 1996, Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids, Endoc Rev, 17, 245, 10.1210/edrv-17-3-245 · DOI · Paper page
- Espersen, 1990, Effect of physical exercise on cytokines and lymphocyte subpopulations in human peripheral blood, APMIS, 98, 395, 10.1111/j.1699-0463.1990.tb01049.x · DOI · Paper page
- Field, 1991, Circulating mononuclear cell numbers and function during intense exercise and recovery, J Appl Physiol, 71, 1089, 10.1152/jappl.1991.71.3.1089 · DOI
Cited by
Miller, G. E., Cohen, S., & Ritchey, A. K. (2002) · Health Psychology · doi:10.1037/0278-6133.21.6.531 · Cited by 769
“In the LPS-stimulated cultures treated with saline (but not dexamethasone), parents of cancer patients exhibited lower average levels of IL-6, greater average levels of TNF-␣, and no differences in IL-1, compared with parents of healthy children.”
BackgroundResultInfluentialStress-Induced Changes in Skin Barrier Function in Healthy Women
Altemus, M., Rao, B., Dhabhar, F. S., Ding, W., & Granstein, R. D. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01373.x · Cited by 347
Oppert, M., Schindler, R., Husung, C., Offermann, K., Gräf, K.-J., Boenisch, O., Barckow, D., Frei, U., & Eckardt, K.-U. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186370.78639.23 · Cited by 327
The Cytokine Response to Physical Activity and Training
Moldoveanu, A. I., Shephard, R. J., & Shek, P. N. (2001) · Sports Medicine · doi:10.2165/00007256-200131020-00004 · Cited by 325
Grootendorst, D. C., Gauw, S. A., Verhoosel, R. M., Sterk, P. J., Hospers, J. J., Bredenbroker, D., Bethke, T. D., Hiemstra, P. S., & Rabe, K. F. (2007) · Thorax · doi:10.1136/thx.2006.075937 · Cited by 286
Self-citation
Metadata
- Authors
- Smits, H. H., Grünberg, K., Derijk, R. H., Sterk, P. J., & Hiemstra, P. S.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-02
- Volume
- 111
- Issue
- 2
- Pages
- 463-468
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W2011637488
- Cited by
- 54
- References
- 2
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytokine release and its modulation by dexamethasone in whole blood following exercise. https://app.cochat.ai/papers/10.1046/j.1365-2249.1998.00482.x
- The paper
- Smits, H. H., Grünberg, K., Derijk, R. H., Sterk, P. J., & Hiemstra, P. S. (2001). Cytokine release and its modulation by dexamethasone in whole blood following exercise. Clinical and Experimental Immunology. https://doi.org/10.1046/j.1365-2249.1998.00482.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.